| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2018 | NEO Neogenomics Inc | Tetrault Lynn A. | Director | Sell | 5,000 | $16.16 | $80,800.00 | -8.9% | |
| Nov 14, 2018 | NEO Neogenomics Inc | Jones Steven C | Executive Vice President | Sell | 141,127 | $16.66 | $2,351,234.56 | -2.0% | |
| Nov 13, 2018 | FLGT Fulgent Genetics, Inc. | Hsieh Ming | President And CEO | Buy | 10,880 | $3.59 | $39,032.00 | +0.2% | |
| Nov 13, 2018 | RVTY Revvity, Inc. | Sullivan Patrick J | Director | Sell | 10,000 | $81.64 | $816,400.00 | -25.8% | |
| Nov 13, 2018 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,446 | $3.50 | $5,062.01 | -0.4% | |
| Nov 13, 2018 | CDNA Caredx, Inc. | Maag Peter82 | See Remarks | Sell | 50,000 | $26.48 | $1,323,945.00 | -11.4% | |
| Nov 12, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 1,866 | $134.49 | $250,960.93 | -4.0% | |
| Nov 12, 2018 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 23,305 | $13.42 | $312,785.67 | -17.9% | |
| Nov 12, 2018 | EXAS Exact Sciences Corp | Zanotti Katherine S50 | Director | Sell | 7,667 | $69.00 | $529,023.00 | -7.0% | |
| Nov 12, 2018 | MTD Mettler Toledo International Inc/ | Kelly Michael A46 | Director | Sell | 2,600 | $603.82 | $1,569,930.00 | -26.9% | |
| Nov 12, 2018 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 163,514 | $69.00 | $11,282,466.00 | -15.6% | |
| Nov 12, 2018 | NEO Neogenomics Inc | Shovlin Robert J. | President, Clinical Services | Sell | 216,493 | $17.00 | $3,680,622.68 | -43.3% | |
| Nov 12, 2018 | NEO Neogenomics Inc | Balliet Jennifer | VP And Chief Culture Officer | Sell | 68,333 | $16.89 | $1,153,964.65 | -49.9% | |
| Nov 9, 2018 | NEO Neogenomics Inc | Johnson Kevin C | Director | Sell | 66,007 | $17.03 | $1,124,179.56 | -27.3% | |
| Nov 9, 2018 | FLGT Fulgent Genetics, Inc. | Hsieh Ming | President And CEO | Buy | 10,000 | $3.36 | $33,610.00 | +0.2% | |
| Nov 8, 2018 | DHR Danaher Corp /de/ | Comas Daniel L | EVP &CFO | Sell | 36,000 | $103.88 | $3,739,524.00 | -12.7% | |
| Nov 7, 2018 | CRL Charles River Laboratories International, Inc. | Johst David P | Corporate Executive VP | Sell | 23,356 | $136.00 | $3,176,416.00 | -10.6% | |
| Nov 7, 2018 | DHR Danaher Corp /de/ | Lutz Robert S | Svp-chief Accounting Officer | Sell | 15,000 | $103.80 | $1,556,970.00 | -45.4% | |
| Nov 7, 2018 | DHR Danaher Corp /de/ | Joyce Thomas Patrick Jr | President And CEO | Sell | 5,212 | $103.89 | $541,464.26 | -3.3% | |
| Nov 7, 2018 | EXAS Exact Sciences Corp | Lidgard Graham Peter | Chief Science Officer | Sell | 38,311 | $75.01 | $2,873,632.88 | -39.7% | |
| Nov 6, 2018 | RVTY Revvity, Inc. | Witz Pascale | Director | Sell | 2,206 | $83.62 | $184,454.69 | -57.0% | |
| Nov 5, 2018 | DHR Danaher Corp /de/ | King William | Senior Vice President | Sell | 53,433 | $101.64 | $5,430,739.10 | -43.6% | |
| Nov 5, 2018 | RVTY Revvity, Inc. | Lopardo Nicholas A | Director | Sell | 2,000 | $82.12 | $164,244.00 | -4.2% | |
| Nov 1, 2018 | EXAS Exact Sciences Corp | Lidgard Graham Peter | Chief Science Officer | Sell | 79,673 | $71.73 | $5,714,841.04 | -15.2% | |
| Oct 31, 2018 | VCYT Veracyte, Inc. | Hall Christopher M | President And COO | Sell | 40,000 | $13.51 | $540,270.60 | -23.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.